You Searched For "cipla covid 19 drug" and got 14 results
Sort By:
4 mins read
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
2 mins read
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
2 mins read
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
2 mins read
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
3 mins read
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
1 min read
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
The EUA is based on available data from two global clinical trials – US National Institute for All…
PTI
2 mins read
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
1 min read
Cipla launches generic remdesivir for COVID-19 patients
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
1 min read
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for rest…
PTI
2 mins read
COVID-19: India's drug regulator may soon give restricted emergency use authorisation to American vaccine Moderna
According to the sources, an approval is likely anytime as the CDSCO is in favour of granting…
PTI
2 mins read
Hyderabad's Avra Labs to make Favipiravir for Cipla's Ciplenza
Hyderabad-based Avra Laboratories Pvt Ltd announced on Monday that it had received regulatory app…
4 mins read
Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill
Pharmaceutical company stocks were the top gainers in a weak market on December 29 as the segment c…
2 mins read
Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across India
"The launch of Covifor in India is a significant milestone for all of us... Through Covifor, we ho…
PTI
1 min read
CSIR-IICT ties up with Cipla to develop anti-COVID-19 drug
Research on anti-viral drugs has been on throughout theworld for long and many companies have devel…